CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $199.03M, lower than 95% of all stocks globally
- PositionOperating margin is 28.2%, higher than 95% of its Medical Care Facilities peers (median 11%)
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.47BTRY199.03M · vs all stocks (USD)
Trailing P/E
13.93xvs Medical Care Facilities peers
Revenue (TTM)
3.43BTRY72.07M · vs all stocks (USD)
Profit Margin
19.67%vs Medical Care Facilities peers
Beta
0.0870xvs all stocks
52-Week Change
-18.46%vs all stocks
Market Capitalization
9.47BTRY199.03M · vs all stocks (USD)
Enterprise Value
9.17BTRY192.69M · vs all stocks (USD)
Trailing P/E
13.93xvs Medical Care Facilities peers
PEG Ratio
2.21xvs Medical Care Facilities peers
Price to Sales (TTM)
2.74xvs Medical Care Facilities peers
Price to Book (MRQ)
1.07xvs Medical Care Facilities peers
Enterprise to Revenue
2.58xvs Medical Care Facilities peers
Enterprise to EBITDA
6.93xvs Medical Care Facilities peers
Gross Margin
33.79%vs Medical Care Facilities peers
Profit Margin
19.67%vs Medical Care Facilities peers
Operating Margin
28.18%vs Medical Care Facilities peers
Return on Assets (TTM)
7.34%vs Medical Care Facilities peers
Return on Equity (TTM)
9.07%vs Medical Care Facilities peers
Revenue (TTM)
3.43BTRY72.07M · vs all stocks (USD)
Revenue per Share (TTM)
8.64TRYUpdated Jul 17, 2026Quarterly Revenue Growth
3.00%vs Medical Care Facilities peers
Gross Profit (TTM)
1.41BTRY29.53M · vs all stocks (USD)
EBITDA (TTM)
1.47BTRY30.93M · vs all stocks (USD)
Net Income (TTM)
695.68MTRY14.62M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-17.70%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
786.45MTRY16.52M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
695.68MTRY14.62M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
1.52MTRYFY2025 · Dec 31, 2025Revenue
3.43BTRYFY2025 · Dec 31, 2025Cost of Goods Sold
2.02BTRYFY2025 · Dec 31, 2025Gross Profit
1.41BTRYFY2025 · Dec 31, 2025Operating Income
974.56MTRY20.48M · vs all stocks (USD)
Pre-tax Income
723.08MTRYFY2025 · Dec 31, 2025Income Tax Expense
27.40MTRYFY2025 · Dec 31, 2025Net Income
695.68MTRYFY2025 · Dec 31, 2025EBIT
1.08BTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.29BTRYFY2025 · Dec 31, 2025Selling, General & Administrative
52.96MTRYFY2025 · Dec 31, 2025Other Operating Expenses
215.44MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
217.75MTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
352.41MTRYFY2025 · Dec 31, 2025Net Income from Continuing Operations
695.68MTRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
786.45MTRYFY2025 · Dec 31, 2025Free Cash Flow
517.59MTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
691.64MTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
695.68MTRYFY2025 · Dec 31, 2025Other Non-cash Items
134.66MTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-66.03MTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.14MTRYFY2025 · Dec 31, 2025Capital Expenditures
-268.85MTRYFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.05MTRYFY2025 · Dec 31, 2025Other Investing Activity
1.90BTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
1.63BTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
124.89MTRYFY2025 · Dec 31, 2025Long-term Debt Payments
-551.79MTRYFY2025 · Dec 31, 2025Common Stock Repurchase
0.00TRYFY2025 · Dec 31, 2025Other Financing Charges
-253.14MTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
-540.82MTRYFY2025 · Dec 31, 2025Shares Outstanding
400.00MSharesUpdated Jul 17, 2026Float Shares
87.24MSharesUpdated Jul 17, 2026% Held by Insiders
74.25%vs all stocks
% Held by Institutions
1.64%vs all stocks
Total Cash (MRQ)
1.10BTRY23.21M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.41TRYUpdated Jul 17, 2026Total Debt (MRQ)
821.25MTRY17.26M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0924xvs Medical Care Facilities peers
Current Ratio (MRQ)
2.37xvs Medical Care Facilities peers
Book Value per Share (MRQ)
22.21TRYUpdated Jul 17, 2026Total Assets
9.57BTRY201.13M · vs all stocks (USD)
Total Current Assets
1.36BTRYFY2025 · Dec 31, 2025Total Liabilities
1.56BTRYFY2025 · Dec 31, 2025Total Non-current Assets
8.22BTRYFY2025 · Dec 31, 2025Total Non-current Liabilities
690.75MTRYFY2025 · Dec 31, 2025Total Current Liabilities
871.95MTRYFY2025 · Dec 31, 2025Cash
683.00MTRYFY2025 · Dec 31, 2025Cash Equivalents
8.64MTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents
691.64MTRYFY2025 · Dec 31, 2025Other Short-term Investments
32.03MTRYFY2025 · Dec 31, 2025Accounts Receivable
361.96MTRYFY2025 · Dec 31, 2025Inventory
112.27MTRYFY2025 · Dec 31, 2025Accounts Payable
272.97MTRYFY2025 · Dec 31, 2025Short-term Debt
350.09MTRYFY2025 · Dec 31, 2025Long-term Debt
40.01MTRYFY2025 · Dec 31, 2025Common Stock (Book)
400.00MTRYFY2025 · Dec 31, 2025Retained Earnings
5.87BTRYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.01BTRY168.29M · vs all stocks (USD)
Treasury Stock
8.19MTRYFY2025 · Dec 31, 202552-Week Low
20.08TRYUpdated Jul 17, 202652-Week High
33.43TRYUpdated Jul 17, 202652-Week Change
-18.46%vs all stocks
Beta
0.0870xvs all stocks
50-Day MA
25.29TRYUpdated Jul 17, 2026200-Day MA
23.92TRYUpdated Jul 17, 2026Avg 10-Day Volume
1.50MSharesUpdated Jul 17, 2026Avg 30-Day Volume
2.12MSharesUpdated Jul 17, 2026Diluted EPS (TTM)
1.70TRYUpdated Jul 17, 20266 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 28.2%, higher than 95% of its Medical Care Facilities peers (median 11%)Significant
Operating margin: 0.28Industry median: 0.11Industry P95: 0.26Peers compared: 70.00
Financial Health
Altman Z-Score 5.28: safe zoneNotable
Altman Z-Score: 5.28
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $199.03M, lower than 95% of all stocks globallySignificant
Market cap (USD): 199,025,664Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.
Chaoju Eye Care Holdings Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Charm Care Corp
Tier 1RuleThroughput-Bound ConversionProductionFlow
C-MER Medical Holdings Ltd.
Tier 1RuleThroughput-Bound ConversionFlowProduction
Sarana Meditama Metropolitan Tbk
Tier 1RuleThroughput-Bound ConversionFlowProduction
Hospital Mater Dei S.A.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Solasto Corporation
Tier 1RuleThroughput-Bound ConversionFlowProduction
Universal Vision Biotechnology Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionInterface
Auna S.A.
Tier 1RuleThroughput-Bound ConversionRiskProduction
Liaoning He Eye Hospital Co., Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Q & M Dental Group (Singapore) Ltd.
Tier 1RuleThroughput-Bound ConversionProductionFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
SJS Enterprises Ltd.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year Revenue And Profit Growth
Classys Inc.
6 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash-Flow Ratios ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthMulti-Year Revenue And Profit Growth
Pharma Research Products Co., Ltd
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityCash-Flow Ratios ElevatedMulti-Year Revenue, Profit, And Income GrowthMulti-Year Revenue And Profit Growth